Article

A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast…

Oxidative Medicine and Cellular Longevity · 2021 · Wei Liang, author Junfeng Shi, author Haiyan Xia, author Xiaowei Wei, author Peeter Karihtala, Academic Editor

Key facts

Title A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway
First author Wei Liang, author Junfeng Shi, author Haiyan Xia, author Xiaowei Wei, author Peeter Karihtala, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Feb 19, 2021
DOI 10.1155/2021/5537737
Product codes mentioned GIA, MVU

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature